Question
Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?
Total Forecasters25
Community Prediction43% (35% - 50%)
Make a Prediction
Authors:
Opened:
Closes:
Scheduled resolution:
Comments
? comments
Authors:
Opened:
Closes:
Scheduled resolution: